This was a single-center retrospective study. We retrospectively analyzed 139 patients who underwent RIRS for the treatment of renal and ureteral stones at the Japanese Red Cross Hadano Hospital in Kanagawa Prefecture between April 2020 and August 2022. This study was approved by the Institutional Review Board of the Japanese Red Cross Hadano Hospital (approval number R4-09). All surgeons or first assistants in this study were Kasahara, the first author, who already had more than 500 cases of upper urinary tract stone treatment and was familiar with the RIRS techniques.
Patients were classified into two groups: the HOT group (underwent surgery from April 2020 to July 2021), in which intraoperative irrigation was performed using saline solution heated to 37°C, and the COLD group (underwent surgery from August 2021 to August 2022), in which saline solution cooled to 4°C was used. Both groups underwent the same surgical technique, and the equipment used is described below.
Patient characteristics and parameters were recorded, including the age, sex, height, weight, body mass index (BMI), pre-existing medical conditions, antiplatelet or anticoagulant medication, pre- and post-operative estimated glomerular filtration rate (eGFR), stone burden, stone location, history of obstructive pyelonephritis within three months before surgery, and presence of ureteral stents before surgery. The stone burden was the sum of the three largest diameters of each stone measured using computed tomography. All patients underwent RIRS in the lithotomy position, and operation outcomes were evaluated by the operative time, surgical complications, stone-free status, presence of postoperative UTI, hospital stay, and blood laboratory tests (C-reactive protein, white blood cell count, and eGFR) on postoperative day 1. The eGFR was calculated using the Cockcroft-Gault formula.
Surgical procedure
RIRS was performed under general or spinal anesthesia. The endoscope used for surgery was an 8.6- to 9.8-Fr semi-rigid ureteroscope (Olympus, Tokyo, Japan) or a 7.5-Fr flexible ureteroscope (URF P-7; Olympus) or both. The lower ureteral stone was approached using a semi-rigid ureteroscope. For upper ureteral or renal stones, ureteral access sheaths (10/12-Fr or 12/14-Fr RETRACE; Coloplast, Humlebæk, Denmark) were used for stone extraction and intrarenal irrigation.
Saline irrigation was manually adjusted by a first assistant to achieve a flow rate of approximately 0.5-1.0 ml/sec. The first surgeon ensured that the injection volume did not significantly exceed the effluent volume so as not to increase the intrarenal pressure. To prevent body hypothermia, a 12-Fr catheter was placed in the bladder intraoperatively, and all cold saline in the bladder was maintained to avoid retention.
Stone fragmentation or dusting was performed using a Lumenis VersaPulse Holmium YAG laser (Boston Scientific, Marlborough, MA, USA). To prevent tissue damage, the power output was limited to ≤ 20 W. For stone removal, a 1.5-Fr Dormia Tipless Stone Extracter (Coloplast) was used. In all cases, a 6-Fr double- or single-J stent was placed at the end of the procedure. A single-J stent was removed after hospital discharge. The double-J stent was removed within one month.
Thermodynamic test of Holmium YAG laser
As a preliminary experiment for the present study, we conducted thermodynamic experiments to determine the extent to which the holmium laser induced temperature changes in the perfusate (Fig. 1). Fibers of 200 µm were immersed in 40 ml of saline solution, and the holmium laser was continuously operated at 15 W (1.5 J × 10 Hz) and 30 W (1.5 J × 20 Hz) for 120 s. The temperature of the saline solution was initially set at 35°C and 4°C before the start of irradiation, and the temperature change was measured 3 times for each combination, resulting in 12 measurements. The results showed that the temperature of 40 ml of the saline solution increased by approximately 5°C when irradiated with 15 W for 120 s, and by approximately 12°C when irradiated at 30 W (Fig. 2).
Perioperative antibiotics
To prevent postoperative UTI, cefazolin (a first-generation cephalosporin antibiotic agent) was administered intravenously on the day of the operation. When a UTI developed, the antibiotic agents were switched to ceftriaxone or tazobactam/piperacillin, depending on the urine culture and general condition.
Infection criteria
Postoperative UTI was defined as a case in which antimicrobial agents were administered for at least three days after surgery with a fever of ≥ 38.0°C, as well as chills, flank pain, nausea, vomiting, costovertebral angle tenderness, and relevant postoperative blood laboratory test findings.
Stone-free status
Stone-free status was defined as confirmed endoscopic stone-free status at operation or no stones larger than 2 mm on abdominal radiography or computed tomography 1 month postoperatively.
Statistical analyses
Statistical analyses were performed using the Statistical Package for the Social Sciences (IBM, New York, NY, USA). Patient characteristics, operation outcomes, and risk factors for postoperative UTI were analyzed using the Mann–Whitney U test and logistic regression.